North American cost analysis of brand name versus generic drugs for the treatment of glaucoma

North American cost analysis of brand name versus generic drugs for the treatment of glaucoma

Monali S Malvankar-Mehta,1,2 Lucy Feng,3 Cindy ML Hutnik1,4 1Department of Ophthalmology, Schulich School of Medicine and Dentistry, The University of Western Ontario, London, Ontario N6A 4V2, Canada; 2Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, The Unive...

Full description

Bibliographic Details
Main Authors: Malvankar-Mehta MS, Feng L, Hutnik CML
Format: Article
Language:English
Published: Dove Medical Press 2019-12-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
cost analysis
brand name drugs
generic drugs
glaucoma
Online Access:https://www.dovepress.com/north-american-cost-analysis-of-brand-name-versus-generic-drugs-for-th-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/north-american-cost-analysis-of-brand-name-versus-generic-drugs-for-th-peer-reviewed-article-CEOR

Similar Items